Status:
COMPLETED
Mindfulness for African Americans Postpartum
Lead Sponsor:
Loyola University
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Mental Disorders of Mother, Postpartum
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
A randomized clinical trial (RCT) design will be used to compare an 8-week Mindfulness for African Americans Postpartum (MAAP) intervention to an 8-week Educational Program (active comparison group). ...
Detailed Description
This project is a first step to assess a culturally-tailored Mindfulness Intervention for African Americans Postpartum (MAAP). Elevated perinatal depressive symptoms are more common among disadvantage...
Eligibility Criteria
Inclusion
- In order to be eligible to participate in this study, an individual must meet all of the following criteria.
- Participants must identify as African American/Black and have given birth to an infant
- Participants will be over the age of 18 and able to speak and read English at a 5th grade level or above.
- Participants must be willing to comply with study procedures including completion of an 8-week intervention or educational program, provide saliva samples 3 times at session 1, 4, and 8, answer questionnaires concerning demographics, and psycho-behavioral health symptoms, and be available for in person and virtual sessions during the duration of the study.
- Participants must be willing to adhere to the MAAP intervention.
- Participants must have access to a smart phone and agree to download the free app Zoom
- Participants must sign and date an informed consent document -
Exclusion
- An individual who meets any of the following criteria will be excluded from participation:
- Participants will be excluded from the study if they are currently using immune medications such as steroids, whether prescribed or not
- Participants are excluded from the study if they have a diagnosis or disease process (physical or psychological) that precludes participation in the MAAP intervention.
Key Trial Info
Start Date :
February 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05280938
Start Date
February 7 2022
End Date
July 31 2024
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loyola University Medical Center
Maywood, Illinois, United States, 60153